Bruce C Cozadd sold $3.3M of Jazz Pharmaceuticals (JAZZ)

Executed Nov 18 2025, disclosed Nov 20 2025, 2 days later.

Value, as filed

$3.3M

18,000 sh across 4 lots

Executed

Nov 18 2025

the trade date, as filed

Disclosed

Nov 20 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Bruce C Cozadd Director profile →

Bruce C Cozadd (Director) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in Jazz Pharmaceuticals plc (JAZZ). The largest single filing was $13.7M of JAZZ (76,993 sh across 3 lots, as filed), executed Nov 26 2025.

The name

JAZZ

Jazz Pharmaceuticals plc JAZZ · Healthcare · 46 filings in 24 months ticker →

Healthcare · Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Bruce C Cozadd in JAZZ

JAZZSALE Jazz Pharmaceuticals plc $1.5M
6,000 sh × $250.13
Exec Sep 1
Filed Sep 2 · 5:03 PM ET JAZZSALE Jazz Pharmaceuticals plc $1.5M
6,000 sh × $252.98
Exec Aug 3
Filed Aug 5 · 4:33 PM ET JAZZSALE Jazz Pharmaceuticals plc $1.4M
6,000 sh × $240.47
Exec Jul 1
Filed Jul 6 · 6:23 PM ET JAZZSALE Jazz Pharmaceuticals plc $1.4M
6,000 sh × $235.12
Exec Jun 1
Filed Jun 3 · 5:30 PM ET JAZZSALE Jazz Pharmaceuticals plc $1.2M
6,000 sh × $203.33
Exec May 1
Filed May 5 · 5:30 PM ET JAZZSALE Jazz Pharmaceuticals plc $1.1M
5,976 sh across 2 lots
Exec Apr 1
Filed Apr 3 · 5:30 PM ET JAZZSALE Jazz Pharmaceuticals plc $1.1M
5,767 sh across 2 lots
Exec Mar 3
Filed Mar 4 · 5:30 PM ET JAZZSALE Jazz Pharmaceuticals plc $13.7M
76,993 sh across 3 lots
Exec Nov 26 2025
Filed Dec 1 2025 · 5:30 PM ET